Structures by: Shakhtshneider T. P.
Total: 9
4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide adipic acid
C14H13N3O4S2,0.5(C6H10O4)
CrystEngComm (2012) 14, 1 305
a=8.3589(9)Å b=10.6257(12)Å c=11.7957(13)Å
α=80.019(10)° β=72.499(10)° γ=73.133(10)°
4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2- benzothiazine-3-carboxamide 1,1-dioxide terephtalic acid
C14H13N3O4S2,0.5(C8H6O4)
CrystEngComm (2012) 14, 1 305
a=8.5979(6)Å b=10.4551(6)Å c=11.7515(7)Å
α=91.355(5)° β=107.856(6)° γ=109.444(6)°
Acetaminophen
C8H9NO2
Acta Crystallographica Section B (2000) 56, 2 299-309
a=6.9800(10)Å b=8.915(2)Å c=11.566(2)Å
α=90.00° β=98.54(3)° γ=90.00°
Acetaminophen
C8H9NO2
Acta Crystallographica Section B (2000) 56, 2 299-309
a=6.8850(10)Å b=8.5819(7)Å c=11.5190(10)Å
α=90.00° β=99.120(10)° γ=90.00°
Acetaminophen
C8H9NO2
Acta Crystallographica Section B (2000) 56, 2 299-309
a=6.8200(10)Å b=8.3740(10)Å c=11.5590(10)Å
α=90.00° β=99.320(10)° γ=90.00°
Acetaminophen
C8H9NO2
Acta Crystallographica Section B (2000) 56, 2 299-309
a=6.6250(10)Å b=7.985(2)Å c=11.916(2)Å
α=90.00° β=99.41(3)° γ=90.00°
Sulfathiazole adduct with pyridine, tetragonal form
C9H9N3O2S2,C5H5N
Acta Crystallographica Section E (2006) 62, 7 o2707-o2709
a=8.385(3)Å b=9.272(2)Å c=20.704(8)Å
α=90.00° β=100.10(3)° γ=90.00°
Sulfathiazole adduct with pyridine, tetragonal form
C9H9N3O2S2,C5H5N
Acta Crystallographica Section E (2006) 62, 7 o2669-o2671
a=8.670(2)Å b=8.670(2)Å c=20.927(10)Å
α=90.00° β=90.00° γ=90.00°
Piroxicam Benzoate
C22H17N3O5S
Acta Crystallographica Section C (2006) 62, 7 o429-o431
a=11.106(3)Å b=16.5606(16)Å c=12.0351(18)Å
α=90° β=111.463(12)° γ=90°